RGS 0.00% 12.0¢ regeneus ltd

Re-rate, page-14

  1. 14 Posts.
    lightbulb Created with Sketch. 1
    Thank you I agree. As a spec stock it appears strong based on what seems to be medical research with integrity and registered technology patents etc. Perhaps the best endorsement is from AGC. I cant imagine AGC would be investing millions without a positive, substantiated view.

    I note with the Edison's latest research, valuation excludes these derived from some current technologies. This could be a good long term story.
 
watchlist Created with Sketch. Add RGS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.